Open AccessThe Ebola virus: a review of progress and development in research
Author(s) -
Yitades Gebre,
Teshome Gebre,
Abena Peters
Publication year - 2014
Publication title -
asian pacific journal of tropical biomedicine/asian pacific journal of tropical biomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.507
H-Index - 61
eISSN - 2588-9222
pISSN - 2221-1691
DOI - 10.12980/apjtb.4.201414b419
Subject(s) - ebola virus , biosafety , case fatality rate , virology , outbreak , ebolavirus , virus , ebola vaccine , pathogenicity , pathogen , medicine , disease , biology , microbiology and biotechnology , immunology , epidemiology , pathology
The Ebola virus was identified in the year 1976 and has caused periodic outbreaks in West African countries. The disease has a case fatality rate up to 90%. Ebola has been classified as a biosafety level four pathogen and there is no currently approved vaccine or treatment for the virus. However, remarkable progress has been demonstrated by researchers in understanding the pathogenicity of the Ebola virus. Several animal models have been cultivated to develop diagnostics, vaccines and therapeutic drugs